Cosmetic cross-reference Noindex: medium evidence

619-05-6

CAS 619-05-6

619-05-6 (CAS 619-05-6) is a pharmaceutical compound with 0 bioactivity targets and 0 adverse event associations.

SOURCE NLM DailyMed

Label records

0

SOURCE EMBL-EBI ChEMBL

Bioactivity

0

SOURCE DrugCentral

Adverse signals

0

SOURCE IUPHAR/BPS

PubMed IDs

0

SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name

619-05-6

CAS Number

619-05-6

UNII

2H2G880K12

InChIKey

HEMGYNNCNNODNX-UHFFFAOYSA-N

ChEMBL ID

CHEMBL3305820

Molecule Type

Small molecule

Source Match

EMBL-EBI ChEMBL (INCHIKEY)

natural product

SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →

SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is 619-05-6 used for in pharmaceutical contexts?

619-05-6 (CAS 619-05-6) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for 619-05-6?

No adverse-event association or SIDER side-effect rows are rendered for 619-05-6 in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is 619-05-6 also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for 3,4-Diaminobenzoic Acid with EU status "prohibited".

What clinical phase is 619-05-6 in?

No phase 1-4 clinical development badge is rendered for 619-05-6 because the matched compound identifier rows do not contain a max-phase value.